No Data
Becton Dickinson & Co. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Becton Dickinson & Co. (BDX) rallied 1.18% to $266.81 Monday, on what proved to be an a
Why Accelerate Diagnostics Shares Are Trading Higher Today
Becton Dickinson and Co (NYSE:BDX) will sell Accelerate Diagnostics Inc's (NASDAQ:AXDX) rapid testing solution for antibiotic resistance and susceptibility, offering results in hours versus one to two
Hot Stocks: AXDX Surges Nearly 25%, EMBC Gains on Earnings, LI Slides on Mixed Earnings, HALO Also Falls
Markets look to start trading on its back foot but shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) have exploded nearly 25% after entering an agreement with Becton, Dickinson and Company (BDX). A
BD, Accelerate to Collaborate on Testing-Kit Distribution
By Connor Hart Becton, Dickinson & Co. and Accelerate Diagnostics Inc. on Monday said the companies would collaborate to bring rapid antimicrobial identification and susceptibility to more clinic
Becton, Dickinson to market Accelerate Diagnostics' rapid tests for antibiotic resistance
Becton, Dickinson and Company (NYSE:BDX) signed an agreement to offer Accelerate Diagnostics' (NASDAQ:AXDX) rapid testing solution for antibiotic resistance and susceptibility. Under the agreement, BD
BD, Accelerate Diagnostics Announce Global Commercial Collaboration
Companies will work together to bring rapid antimicrobial identification and susceptibility diagnostics to more clinicians and patients worldwide FRANKLIN LAKES, N.J. and TUCSON, Ariz., Aug. 15, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (
Becton Dickinson & Co. Stock Rises Friday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Becton Dickinson & Co. (BDX) rose 1.65% to $263.69 Friday, on what proved to be an all-
Looking Into Becton's Return On Invested Capital
 According to Benzinga Pro, during Q3, Becton (NYSE:BDX) earned $360.00 million, a 20.7% increase from the preceding quarter. Becton's sales decreased to $4.64 billion, a 7.38% change since Q2. In Q
Becton Dickinson & Co. Stock Outperforms Market On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Becton Dickinson & Co. (BDX) inched 0.32% higher to $259.40 Thursday, on what proved to
FDA Says Becton Dickinson Recalls Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits, And Intraosseous Powered Drivers
FDA Says Becton Dickinson Recalls Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits, And Intraosseous Powered Drivers
Loading...